PEAK6 Group’s Repligen RGEN Stock Holding History

PEAK6 Group’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-12,922	Closed	-$495K	–	4674
2017 Q3	$495K	Buy	+12,922	New	+$542K	﹤0.01%	2563
2016 Q1	–	Sell	-3,900	Closed	-$95.4K	–	4944
2015 Q4	$110K	Buy	+3,900	New	+$112K	﹤0.01%	3902

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PEAK6 Group's RGEN Position: Q4 2017 in Review

PEAK6 Group sold out of Repligen (RGEN) in Q4 2017, closing a stake of 12,922 shares — an estimated $495K sold.

PEAK6 Group first reported a position in RGEN in Q4 2015 and held it in 2 quarters. The position peaked at $495K in Q3 2017. 184 funds tracked by Wall St. Rank hold RGEN as of Q4 2017.

PEAK6 Group reported no remaining Repligen position as of Q4 2017 after selling out during the quarter.
PEAK6 Group sold 12,922 Repligen shares in Q4 2017, an estimated $495K.
PEAK6 Group first reported a position in Repligen in Q4 2015 and held it in 2 quarters.
PEAK6 Group's Repligen position peaked at $495K in Q3 2017.
184 funds tracked by Wall St. Rank held Repligen as of Q4 2017.

Based on PEAK6 Group's 13F filing for Q4 2017, filed 14 Feb 2018.